| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 227,346 | 231,970 | 243,336 | 237,268 | | Cost of Revenue | 69,793 | 56,251 | 53,399 | 41,079 | | | Gross Profit | 157,553 | 175,719 | 189,937 | 196,189 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 24,521 | 23,026 | 33,536 | 56,858 | | Non Recurring |
-
|
-
| 704,731 | 886,457 | | Others | 106,218 | 100,282 | 94,805 | 92,095 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 26,814 | 52,411 | (643,135) | (839,221) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 56 | 302 | 85 | 386 | | Earnings Before Interest And Taxes | 26,870 | 52,713 | (643,050) | (838,835) | | Interest Expense | 19,702 | 16,972 | 14,402 | 2,757 | | Income Before Tax | 7,168 | 35,741 | (657,452) | (841,592) | | Income Tax Expense | 2,946 | 18,528 | (233,334) | (192,672) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,222 | 17,213 | (424,118) | (648,920) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,222 | 17,213 | (424,118) | (648,920) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,222 | $17,213 | ($424,118) | ($648,920) |
|
0.67% Nasdaq 0.00%
Income Statement
